	US 12,343,363 B2
	*Lactic acid bacterial composition for the treatment of bacterial vaginal infections by Gardnerella vaginalis* and, if present, of concurrent fungal infections**
Giovanni Mogna, Novara (IT)
Assigned to PROBIOTICAL S.P.A., Novara (IT)
Filed by PROBIOTICAL S.P.A., Novara (IT)
Filed on Oct. 15, 2020, as Appl. No. 17/071,947.
Application 17/071,947 is a continuation of application No. 16/087,609, abandoned, previously published as PCT/IB2017/051710, filed on Mar. 24, 2017.
Claims priority of application No. 102016000031269 (IT), filed on Mar. 24, 2016.
Prior Publication US 2021/0023150 A1, Jan. 28, 2021
Int. Cl. A61K 35/747 (2015.01); A23L 33/135 (2016.01); A61K 9/00 (2006.01); A61P 15/02 (2006.01); A61P 31/04 (2006.01); A61P 31/10 (2006.01); A61P 31/22 (2006.01)

CPC A61K 35/747 (2013.01) [A23L 33/135 (2016.08); A61K 9/0034 (2013.01); A61K 9/0053 (2013.01); A61P 15/02 (2018.01); A61P 31/04 (2018.01); A61P 31/10 (2018.01); A61P 31/22 (2018.01)]

12 Claims

1. A method of treating a vaginal infection, the method comprising

administering to a subject a formulation, comprising at least one pharmaceutical or food-grade excipient and bacteria comprising at least a first strain of bacteria belonging to the species Lactobacillus fermentum; said formulation being a vaginal formulation in liquid form and/or an oral formulation,

wherein said vaginal infection comprises vaginal infection by the pathogenic bacterium Gardnerella vaginalis, and

wherein the first strain comprises strain LF05 with deposit number DSM 32277 or CNCM I-789.